Skip to main content
. 2022 Mar 31;27(1):108–120. doi: 10.3746/pnf.2022.27.1.108

Table 3.

Quantitative electroencephalograph data of rats before and after dosing with ashwagandha extract

Time point EEG band Power (micro V2/Hz)

50 mg/kg 25 mg/kg 10 mg/kg



Mean±SD % Change P-value Mean±SD % Change P-value Mean±SD % Change P-value
Baseline value Gamma 4.67±3.91 4.49 0.5313 4.54±12.66 14.53 0.0625 4.40±5.65 11.13 0.0938
Post treatment Gamma 4.88±5.08 5.20±5.91 4.89±4.79
Baseline value Delta 1.63±2.26 33.74 0.4468 2.60±3.35 29.61 0.0313* 2.05±2.89 45.85 0.0313*
Post treatment Delta 2.18±1.86 3.37±4.08 2.99±3.45
Baseline value Theta 6.92±7.82 2.45 0.6427 6.73±6.45 6.98 0.1563 7.49±8.39 4.93 0.3125
Post treatment Theta 7.09±7.50 7.20±7.02 7.86±8.60
Baseline value Beta 3.50±4.18 15.71 0.057 3.79±4.31 17.15 0.0625 3.92±4.52 13.77 0.0313*
Post treatment Beta 4.05±4.86 4.44±4.04 4.46±3.95
Baseline value Alpha 9.02±3.77 1.10 0.6898 8.56±8.61 66.83 0.0938 9.17±2.93 65.53 0.2188
Post treatment Alpha 9.12±3.27 2.84±2.91 3.16±3.79

Data extracted with AcqKnowledge software version 4.4 (Biopac Systems, Inc.).

*P<0.05 by Wilcoxon test.

EEG, electroencephalogram.

HHS Vulnerability Disclosure